TrialPath
Recruiting

Basic and Clinical Research of Pregnancy-Induced Hypertension

NCT07464379 · Second Affiliated Hospital of Wenzhou Medical University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Collect Blood Pressure, Blood, Amniotic Fluid, Placenta and Other Samples From Normal Pregnant Women, Patients With Pregnancy-induced Hypertension and Those Who Have Experienced Miscarriage, and Conduct Tests on Them.
About this study
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
Eligibility criteria
Inclusion Criteria: \- Healthy pregnant women, patients with miscarriage, etc. Exclusion Criteria: * Heart disease, infections, etc. in pregnant women Uncooperative patients
Study design
Enrollment target: 100 participants
Age groups: adult
Timeline
Starts: 2020-01-01
Estimated completion: 2028-12-31
Last updated: 2026-03-11
Interventions
Other: no Intervention
Primary outcomes
  • PIH (Early pregnancy:Weeks 1 to 12 (the first to third months of pregnancy) ;mid-pregnancy:Weeks 13 to 27 (the 4th to 6th month of pregnancy) ;post-delivery period:Weeks 28 to 40 (the 7th to 9th months of pregnancy);the day of delivery。)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · other
Contacts & investigators
ContactQian Wang, PHD · contact · wqian84@163.com · 13587638653
InvestigatorQian Wang · study_chair, The Second Affiliated Hospital of wenzhou Medical University Longwan Branch
All locations (1)
The Second Affiliated Hospital of Wenzhou Medical UniversityRecruiting
Wenzhou, Zhejiang, China
Basic and Clinical Research of Pregnancy-Induced Hypertension · TrialPath